CB Scientific (CB Scientific) Debt-to-Asset : 0.14 (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is CB Scientific Debt-to-Asset?

CB Scientific's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.06 Mil. CB Scientific's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.00 Mil. CB Scientific's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was $0.39 Mil. CB Scientific's debt to asset for the quarter that ended in Dec. 2023 was 0.14.

CB Scientific Debt-to-Asset Historical Data

The historical data trend for CB Scientific's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CB Scientific Debt-to-Asset Chart

CB Scientific Annual Data

Trend

Mar21

Mar22

Mar23

Debt-to-Asset

1.25

0.07

0.33

CB Scientific Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Asset	Get a 7-Day Free Trial							0.58	0.33	0.54	0.63	0.14

Competitive Comparison of CB Scientific's Debt-to-Asset

For the Medical Instruments & Supplies subindustry, CB Scientific's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CB Scientific's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CB Scientific's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where CB Scientific's Debt-to-Asset falls into.

CB Scientific Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

CB Scientific's Debt-to-Asset for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.1	+	0)	/	0.305
	=	0.33

CB Scientific's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.056	+	0)	/	0.39
	=	0.14

CB Scientific (OTCPK:CBSC) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

CB Scientific Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of CB Scientific's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

CB Scientific (CB Scientific) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CB Scientific Inc (OTCPK:CBSC) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

10845 Griffith Peak Drive, Suite 200, Las Vegas, NV, USA, 89135

Website

https://www.cbscientificinc.com

CB Scientific Inc through its U.S. and international subsidiaries provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. The FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.